Q4 26 EPS
$2.06
BEAT +6.45%
Est. $1.94
Q4 26 Revenue
$836.0M
BEAT +3.08%
Est. $811.0M
vs S&P Since Q4 26
-9.3%
TRAILING MARKET
VEEV +1.5% vs S&P +10.8%
Full Year 2026 Results
FY 26 EPS
$8.10
BEAT +2.02%
Est. $7.94
FY 26 Revenue
$3.20B
BEAT +0.76%
Est. $3.17B
Market Reaction
Did VEEV Beat Earnings? Q4 2026 Results
Veeva Systems closed out fiscal 2026 on a high note, posting Q4 non-GAAP diluted EPS of $2.06 against a consensus estimate of $1.94, a 6.19% beat that extended the company's streak to four consecutive quarters of topping analyst expectations, while r… Read more Veeva Systems closed out fiscal 2026 on a high note, posting Q4 non-GAAP diluted EPS of $2.06 against a consensus estimate of $1.94, a 6.19% beat that extended the company's streak to four consecutive quarters of topping analyst expectations, while revenue of $835.95 million came in 2.98% ahead of the $811.77 million consensus and grew 16.0% year over year. Investors had been watching closely heading into the print, and the results did not disappoint. The primary engine behind the quarter's strength was subscription revenue, which rose 16% year over year to $707.75 million, reflecting durable demand across Veeva's life sciences cloud platform. Momentum in the Vault CRM transition, now with more than 125 customers live globally, including two top-20 biopharmas, also reinforced the company's commercial execution narrative. Looking ahead, Veeva guided fiscal Q1 2027 revenue to $855–$858 million and full-year fiscal 2027 revenue to $3.59–$3.60 billion, keeping the company firmly on its path toward a $6 billion revenue run rate by 2030.
Key Takeaways
- • Subscription revenue grew 16% year over year in Q4, driven by continued customer expansion and new wins
- • Non-GAAP operating margin expanded to 43.8% in Q4 from 42.7% a year ago
- • Strong momentum in Development Cloud and Quality Cloud with several top 20 biopharma wins
- • Crossix had a breakout year with strong growth in Measurement and Audiences
VEEV YoY Financials
Q4 2026 vs Q4 2025, source: SEC Filings
VEEV Revenue by Segment
With YoY comparisons, source: SEC Filings
“The agentic transformation underway represents a substantial opportunity for Veeva and life sciences. With our core systems of record spanning the industry's most critical functions and unique datasets, we can deliver industry-specific AI deeply integrated into our applications. Our progress with Veeva AI and continued strong execution in Commercial Cloud, Development Cloud, and Quality Cloud will create significant value for the industry.”
— Peter Gassner, Q4 2026 Earnings Press Release
VEEV Earnings Trends
VEEV vs Market 30 Day Price Reactions
30-day stock return vs benchmark after each earnings
VEEV EPS Trend
Earnings per share: estimate vs actual
VEEV Revenue Trend
Quarterly revenue: estimate vs actual
VEEV Quarterly Results
6 quarters of earnings data
| Quarter | EPS Est. | EPS Act. | Surprise | Revenue | Rev. Surprise |
|---|---|---|---|---|---|
| Q1 27 BEAT | $2.14 | $2.24 | +4.91% | $882.9M | +2.94% |
| Q4 26 BEAT FY | $1.94 | $2.06 | +6.45% | $836.0M | +3.08% |
| FY Full Year | $7.94 | $8.10 | +2.02% | $3.20B | +0.76% |
| Q3 26 BEAT | $1.95 | $2.04 | +4.55% | $811.2M | +2.35% |
| Q2 26 BEAT | $1.90 | $1.99 | +4.73% | $789.1M | +2.65% |
| Q1 26 BEAT | $1.74 | $1.97 | +12.98% | $759.0M | +4.22% |
| Q4 25 BEAT FY | $1.58 | $1.74 | +10.05% | $720.9M | +3.07% |
| FY Full Year | $6.45 | $6.60 | +2.29% | $2.75B | +0.82% |